The novel mAbs reacted with podoplanin-expressing cancer cell lines, including LN31913, PC-1023, NCI-H22624, LN229/hPDPN, RERF-LC-AI/hPDPN, Y-MESO14/hPDPN16, and HSC3/hPDPN (Figure 2c). The gene discussed is PDPN; the disease is cancer.